Coronavirus: Commission approves contract with BioNTech-Pfizer alliance to ensure access to a potential vaccine

(Credit: Unsplash)

This article is brought to you in association with the European Commission.


Today, the European Commission approved a fourth contract with pharmaceutical companies BioNTech and Pfizer, which provides for the initial purchase of 200 million doses on behalf of all EU Member States, plus an option to request up to a further 100 million doses, to be supplied once a vaccine has proven to be safe and effective against COVID-19. Member States can decide to donate the vaccine to lower and middle-income countries or to re-direct it to other European countries.

Today’s contract with the BioNTech-Pfizer alliance builds upon the broad portfolio of vaccines to be produced in Europe, including the already signed a contracts with AstraZeneca, Sanofi-GSK and Janssen Pharmaceutica NV, and the concluded successful exploratory talks with CureVac and Moderna. This diversified vaccines portfolio will ensure Europe is well prepared for vaccination, once the vaccines have been proven to be safe and effective.

President of the European Commission, Ursula von der Leyen, said:  “In the wake of Monday’s promising announcement by BioNTech and Pfizer on the prospects for their vaccine, I’m very happy to announce today’s agreement with the European company BioNTech and Pfizer to purchase 300 million doses of the vaccine. With this fourth contract we are now consolidating an extremely solid vaccine candidate portfolio, most of them in advanced trials phase. Once authorised, they will be quickly deployed and bring us closer to a sustainable solution of the pandemic.

Stella Kyriakides, Commissioner for Health and Food Safety, said: “A safe and effective vaccine is the only lasting exit strategy from the pandemic, and is at the centre of our European Vaccine Strategy. Today’s agreement follows the encouraging first indications from the clinical trial results and is further evidence of our commitment to putting more Europe in the area of health. It is a very telling example of what the EU can achieve when working together, as a Union, and a case in point of what a future European Health Union will be able to deliver.”

BioNTech is a German company working with US-based Pfizer to develop a new vaccine based on messenger RNA (mRNA). mRNA plays a fundamental role in  biology, transferring instructions from DNA to cells’ protein making machinery. In an mRNA vaccine, these instructions make harmless fragments of the virus which the human body uses to build an immune response to prevent or fight disease.

The Commission has taken a decision to support this vaccine based on a sound scientific assessment, the technology used, the companies’ experience in vaccine development and their production capacity to supply the whole of the EU.

Background

The European Commission presented on 17 June a European strategy to accelerate the development, manufacturing and deployment of effective and safe vaccines against COVID-19. In return for the right to buy a specified number of vaccine doses in a given timeframe, the Commission finances part of the upfront costs faced by vaccines producers in the form of Advance Purchase Agreements. Funding provided is considered as a down-payment on the vaccines that will actually be purchased by Member States.

Since the high cost and high failure rate make investing in a COVID-19 vaccine a high-risk decision for vaccine developers, these agreements will therefore allow investments to be made that otherwise might not happen.

Once vaccines have been proven to be safe and effective and have been granted market authorisation by the European Medicines Agency, they need to be quickly distributed and deployed across Europe. On 15 October, the Commission set out the key steps that Member States need to take to be fully prepared, which includes the development of national vaccination strategies. The Commission is putting in place a common reporting framework and a platform to monitor the effectiveness of national vaccine strategies.

The European Commission is also committed to ensuring that everyone who needs a vaccine gets it, anywhere in the world and not only at home. No one will be safe until everyone is safe. This is why it has raised almost €16 billion since 4 May 2020 under the Coronavirus Global Response, the global action for universal access to tests, treatments and vaccines against coronavirus and for the global recovery and has confirmed its interest to participate in the COVAX Facility for equitable access to affordable COVID-19 vaccines everywhere. As part of a Team Europe effort, the Commission announced is contributing with €400 million in guarantees to support COVAX and its objectives in the context of the Coronavirus Global Response.

the sting Milestones

Featured Stings

Can we feed everyone without unleashing disaster? Read on

These campaigners want to give a quarter of the UK back to nature

How to build a more resilient and inclusive global system

Stopping antimicrobial resistance would cost just USD 2 per person a year

UN chief pays tribute to the courage of DR Congo citizens, and the sacrifice of blue helmets

Low productivity jobs continue to drive employment growth

How can we build a workforce for our digital future?

Why the ocean holds the key to sustainable development

One day your doctor might prescribe healthy food and a museum visit – here’s why

7 ways to break the fast fashion habit – and save the planet

EU invests more than €100 million in new LIFE Programme projects to promote a green and climate-neutral Europe

EC v Samsung: A whole year to compile a case

Autumn 2019 Economic Forecast: A challenging road ahead

3 ways to nurture collaboration between universities and industry

Scotland in United Kingdom: It’s either the end or the beginning of the end

A 10-step plan to save our seas

After globalization what? Europe’s long, straining shake-up post Davos wreckage

What keeps me up at night? Two strategists reply

The Silent Pandemic: The impact of the COVID-19 pandemic on mental health

5G networks: to slice or not to slice?

Migration Crisis: how to open the borders and make way for the uprooted

Stop wars disguised as peace missions

Ship Recycling is the Commission’s Titanic

Madagascar: UN Secretary-General reaffirms support for electoral process

Glasgow and Edinburgh race to become the UK’s first net-zero emissions city

Asking for more restriction on intra EU immigration: Unproductive and politically dangerous

3 tech design principles to help curb digital repression

Is your business model fit for the Fourth Industrial Revolution?

Plastic waste from Western countries is poisoning Indonesia

Why Europe is more competitive than the US

Commission reports on progress made by Albania and North Macedonia

Is Data Privacy really safe seen through Commissioner’s PRISM?

How can entrepreneurship tackle the migration crisis in the EU?

EU consumer rules: Airbnb cooperates with European Commission and EU consumer authorities improving the way it presents offers

5 of the world’s deadliest infectious diseases

The Banking Union divides deeply the European Union

3 reasons why responsibly-deployed technology is key to the COVID recovery

5 ways to make your organization a great sustainability partner

Soccer is back with strict COVID-19 rules. Here’s what you need to know

6 young leaders who are improving the state of the world on International Youth Day

Death as a Global Public Health Issue

Nearly half a billion people can’t find decent work; unemployment set to rise: new UN labour report

The road ahead to building a more sustainable world

These Indian fishermen take plastic out of the sea and use it to build roads

Somalia: UN congratulates Puntland region’s newly-elected President

The importance of Yellow September and suicide prevention in Brazil

EU announces €25 million for education in crisis contexts and €140 million to support research in sustainable food systems

Draghi tells the Parliament the ECB to use all its weaponry; euro slides to parity with the dollar

Financial support for workers affected by no-deal Brexit

Youth Internationalization: part of everyday life in JADE

Planes can now fly for 21 hours non-stop. But are people ready?

ECB readies itself for extraordinary monetary measures defying Germany

State aid: Commission approves €1 billion Cypriot scheme to support enterprises and self-employed individuals in context of coronavirus outbreak

Europe divided: 30 years on from the fall of the Berlin Wall

3 things to know about India’s space programme

European Youth Event 2020: giving a voice to young people to influence EU policy

Fairer and clearer rules on social benefits for EU mobile workers agreed

Gender Equality in Medicine: are we now so different from the Middle Ages?

COP21 Breaking News_12 December: The New Draft Agreement!

Common charger: a long-awaited proposal requested by Parliament

Kosovo elections: ‘Most significant change’ in 12 years, Security Council hears

International community urged to deliver on promise for better future for Bosnia and Herzegovina

EU decides “in absentia” of civil society

Europe’s far-right launches attacks on neighboring nations

More Stings?

Speak your Mind Here

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: